Arvinas CEO Randy Teel describes the idea behind PROTAC protein degraders.
1:35
Arvinas CEO Randy Teel describes the idea behind PROTAC protein degraders.
263 views8 months ago
TikTokbiotechtv
What makes Angela Cacace excited about PROTAC protein degradation technology
1:01
What makes Angela Cacace excited about PROTAC protein degradation technology
59 viewsNov 21, 2024
VimeoArvinas Communications
The worst drug disaster in history built medicine's newest weapon 🧬 #Shorts
1:05
The worst drug disaster in history built medicine's newest weapon 🧬 #Shorts
1 views3 months ago
YouTubeLife Sciences AI Applications
Arvinas Journey IV - Companions
3:00
Arvinas Journey IV - Companions
1 week ago
YouTubeKelrain - Topic
Targeted protein degraders have officially moved from promise to proof.From the first FDA-approved PROTAC therapy (Veppanu from Arvinas) to billion-dollar partnerships (Nurix Therapeutics/Roche)… | Ray Dogum
0:33
Targeted protein degraders have officially moved from promise to proof.From the first FDA-approved PROTAC therapy (Veppanu from Arvinas) to billion-dollar partnerships (Nurix Therapeutics/Roche)… | Ray Dogum
3 views4 months ago
linkedin.com
Arvinas | LinkedIn
Arvinas | LinkedIn
Feb 14, 2017
linkedin.com
Weekly Medication Recap 5/4/26 – New FDA approval for Caplyta, Breztri, Veppanu, Jakafi XR & more
2:06
Weekly Medication Recap 5/4/26 – New FDA approval for Caplyta, Breztri, Veppanu, Jakafi XR & more
60 views6 months ago
YouTubeGuideline Central
0:14
🔥 Today’s NASDAQ BIOMEDICAL Stocks (December 8, 2025) 🔥
905 views11 months ago
YouTubeStockometry
1:01
💊🔄 𝗙𝗗𝗔 𝗗𝗥𝗨𝗚 𝗔𝗣𝗣𝗥𝗢𝗩𝗔𝗟𝗦 𝗜𝗡 𝟮𝟬𝟮𝟰: 𝗣𝗢𝗟𝗜𝗖𝗬 𝗦𝗛𝗜𝗙𝗧𝗦 𝗥𝗘𝗦𝗛𝗔𝗣𝗘 𝗣𝗛𝗔𝗥𝗠𝗔'𝗦 𝗣𝗟𝗔𝗬𝗕𝗢𝗢𝗞📜 💊🔄
80 viewsOct 25, 2025
YouTubeAI Biopharma Playbook
1:38
GT20029 estimated release date
2.2K views11 months ago
YouTubeFedyMD
1:10
How vepdegestrant works: the first FDA-approved protein degrader #biotech
2 views4 weeks ago
YouTubeBiotech Distilled
1:56
癌症抗藥性的終結者！FDA核准史上首顆 PROTAC 新藥，顛覆幾十年抗癌邏輯！美股生技下一個翻倍賽道是它？ #ai美股黑帶學院 #美股 #skool
249 views5 months ago
YouTubeAl美股黑帶學院USBB
0:47
Arvinas, Inc.: Pioneering Biotech or a Risky Bet in Drug Discovery? (ARVN)
54 views3 months ago
YouTubegalangbi
0:54
아르비나스, 바이오 혁신인가? 고위험 고수익의 신약 개발 여정 (ARVN)
290 views3 months ago
YouTubegalangbi
1:08
ARVN: The $18 "FDA Catalyst" Play? 🧬 My Arvinas Trade Setup
12 views9 months ago
YouTubeMacroScope
Deciphera Pharmaceuticals | LinkedIn
May 28, 2015
linkedin.com
CAMP4 Therapeutics | LinkedIn
Apr 27, 2018
linkedin.com
Arvinas Shares Promising Phase 1 Clinical Results for ARV-102, a Novel PROTAC Deutetrabenazine Candidate, Demonstrating Effective Target Degradation – Archyde
Oct 5, 2025
archyde.com
See more
Static thumbnail place holder